Is it worthy to treat hidradenitis suppurativa with adalimumab in patients with melanoma and other debilitating systemic diseases? A series of clinical dilemmas.

Authors :: Zhao CY
Fernández-Peñas P
Source :: The Australasian journal of dermatology [Australas J Dermatol] 2018 Nov; Vol. 59 (4), pp. e297-e298. Date of Electronic Publication: 2018 Apr 19.
Publication Year :: 2018

Subjects :: Adalimumab adverse effects
Adult
Hidradenitis Suppurativa complications
Hidradenitis Suppurativa diagnosis
Humans
Male
Melanoma diagnosis
Middle Aged
Patient Safety
Risk Assessment
Sampling Studies
Skin Neoplasms diagnosis
Adalimumab therapeutic use
Hidradenitis Suppurativa drug therapy
Melanoma complications
Skin Neoplasms complications

Full Text Access

Tools